Key result
Cochrane protocol evaluates 18F-FDG-PET/CT diagnostic accuracy for detecting Ewing sarcoma metastases at first diagnosis.
Why the study?
The accuracy of 18F-FDG-PET/CT imaging for detecting metastases of Ewing sarcoma at first diagnosis was uncertain.
Does 18F-FDG-PET/CT imaging accurately detect metastases in patients with Ewing sarcoma at first diagnosis?
Does 18F-FDG-PET/CT imaging accurately detect metastases in patients with Ewing sarcoma at first diagnosis?
This is a protocol for a Cochrane Review to evaluate the diagnostic accuracy of 18F-FDG-PET/CT for detecting metastases in Ewing sarcoma.
Protocol leaves 18F-FDG-PET/CT role in Ewing sarcoma staging undetermined; systematic accuracy data needed before any clinical adoption.
This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: To determine the accuracy of 18F‐FDG‐PET/CT imaging for detection of metastases of Ewing sarcoma (lymph node, bone, bone marrow or lung) at first diagnosis.
No takes yet. Share an insight, caveat, or question.
Haveman et al. (2016) studied this question. 18F-FDG-PET/CT imaging is being evaluated in a Cochrane Review protocol to determine its diagnostic accuracy for detecting metastases of Ewing sarcoma at first diagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: